Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Compass Therapeutics (CMPX)

Compass Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CMPX
DateTimeSourceHeadlineSymbolCompany
19/02/202520:10AllPennyStocks.comMassachusetts-Based Biotech Soars On Analyst Coverage And Bullish Price TargerNASDAQ:CMPXCompass Therapeutics Inc
13/02/202522:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
13/02/202522:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
13/02/202522:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
13/02/202522:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
12/02/202514:39Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CMPXCompass Therapeutics Inc
04/02/202520:45Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CMPXCompass Therapeutics Inc
29/01/202513:00GlobeNewswire Inc.Compass Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech ConferenceNASDAQ:CMPXCompass Therapeutics Inc
08/01/202517:15AllPennyStocks.comAnother Day, Another Biotech Stealing The ShowNASDAQ:CMPXCompass Therapeutics Inc
08/01/202513:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
08/01/202513:00GlobeNewswire Inc.Compass Therapeutics Provides Corporate Update and Announces Advancement of a New Drug CandidateNASDAQ:CMPXCompass Therapeutics Inc
10/12/202419:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
10/12/202419:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
10/12/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
10/12/202413:00GlobeNewswire Inc.Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial OfficerNASDAQ:CMPXCompass Therapeutics Inc
02/12/202413:00GlobeNewswire Inc.Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:CMPXCompass Therapeutics Inc
13/11/202413:30GlobeNewswire Inc.Compass Therapeutics to Participate in Upcoming Investor EventsNASDAQ:CMPXCompass Therapeutics Inc
12/11/202413:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
12/11/202413:00GlobeNewswire Inc.Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
08/11/202415:05GlobeNewswire Inc.Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:CMPXCompass Therapeutics Inc
04/10/202414:31GlobeNewswire Inc.Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual MeetingNASDAQ:CMPXCompass Therapeutics Inc
09/09/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CMPXCompass Therapeutics Inc
03/09/202412:00GlobeNewswire Inc.Compass Therapeutics to Participate in Upcoming Investor EventsNASDAQ:CMPXCompass Therapeutics Inc
30/08/202421:23Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CMPXCompass Therapeutics Inc
14/08/202412:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
12/08/202412:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMPXCompass Therapeutics Inc
12/08/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPXCompass Therapeutics Inc
12/08/202412:00GlobeNewswire Inc.Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:CMPXCompass Therapeutics Inc
09/08/202420:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CMPXCompass Therapeutics Inc
07/08/202412:00GlobeNewswire Inc.Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare ConferenceNASDAQ:CMPXCompass Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CMPX